Pharmaceutical Development And Technology SCIESCI

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.

Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:

-Preformulation and pharmaceutical formulation studies

-Pharmaceutical materials selection and characterization

-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation

-QbD in the form a risk assessment and DoE driven approaches

-Design of dosage forms and drug delivery systems

-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies

-Drug delivery systems research and quality improvement

-Pharmaceutical regulatory affairs

This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

Pharmaceutical Development & Technology 发表关于传统和新型药物输送系统的设计、开发、制造和评估的研究，强调理论和研究问题的实际解决方案和应用。该杂志旨在发表重要的、创新的和原创的研究，以推进药物开发和技术的前沿。

通过原创文章、评论（鼓励事先与 EIC 讨论）、简短报告、书评和技术说明，药物开发与技术涵盖以下方面：

-预制剂和药物制剂研究

-药材选择与表征

-制药工艺开发、工程、放大和工业化以及工艺验证

-QbD 形式为风险评估和 DoE 驱动的方法

-剂型和给药系统的设计

-专注于个性化治疗的新兴药物配方和给药技术

-给药系统研究和质量改进

-药品监管事务

本期刊不考虑发表纯粹关注临床评估、植物药或动物模型的手稿。

该刊已被国际权威数据库SCIE、SCI收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-药学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为3.4，平均审稿速度为约1.0个月，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。